How Cameroon plans to conquer the ECCAS and Nigerian pharmaceutical markets
With technical support from the United Nations Economic Commission for Africa (ECA), public and private sector representatives have consolidated a comprehensive framework to render Cameroon’s local pharmaceutical sector better structured, resilient, productive, competitive and viable in the short term. Within this new dispensation, the Government of Cameroon hopes to steer local actors to capture a more sizeable part of the circa the FCFA 200 billion (US$ 369 million) local market for pharmaceuticals and make inroads into the ECCAS sub regional and Nigerian markets. ECA and Cameroonian experts agree that three main issues are responsible for stunting the growth of the pharmaceutical sector, which structural weakness made the country, like its African counterparts, most vulnerable to the double-jeopardy of the COVID-19 on public health the economy. These are: the lack of competitiveness, reputational issues and limited levels of partnership. The Initiative seeks to reverse the dependency of Africa on outside medical supplies, in the long run. ECA estimates that the continent spends about US$16billion annually to import about 94% of its pharmaceutical and medicinal needs.
| Format: | Press release biblioteca |
|---|---|
| Language: | eng |
| Published: |
2021-01
|
| Online Access: | https://hdl.handle.net/10855/45526 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|